Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk

Area of Science:

• Metabolic disease research
• Biomarker discovery
• Cardiovascular health

Background:

• Apolipoprotein C-III (apoC-III) is implicated in diabetes pathogenesis.
• High-density lipoprotein (HDL) plays a role in metabolic regulation.
• The influence of apoC-III on HDL's antidiabetogenic properties requires investigation.

Purpose of the Study:

• To examine the association between plasma apoC-III concentrations and diabetes risk.
• To investigate the relationship between HDL subspecies (with or without apoC-III) and diabetes risk.
• To determine if apoC-III on HDL modifies its cholesterol concentration's association with diabetes.

Main Methods:

• A case-cohort study design was employed within the Danish Diet, Cancer, and Health Study.
• Baseline plasma concentrations of apoC-III and HDL subspecies were measured.
• Cox regression models were used to analyze associations with incident diabetes risk.

Main Results:

• Elevated apoC-III levels were strongly associated with increased diabetes risk.
• HDL cholesterol without apoC-III showed an inverse association with diabetes risk.
• HDL cholesterol with apoC-III was not significantly associated with diabetes risk, indicating heterogeneity.

Conclusions:

• ApoC-III is a significant risk marker for diabetes.
• The presence of apoC-III on HDL may diminish HDL's protective effects against diabetes.
• ApoC-III presents a potential therapeutic target for diabetes prevention.